- Hjem
- Amsterdam
- Selskapsmeldinger
- Archive
- Company press releases
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
15 Feb 2023 18:00 CET |
Boussard Gavaudan | BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR) - Final NAV | 30204000 Closed End Investments | Other subject |
15 Feb 2023 17:30 CET |
DISRUPTIVE CAPITAL SHARES | Update on Business Combination Discussions; Results of Extraordinary General Meeting re Stub Tender Offer; and Update on Repurchase Offer | 30205000 Open End and Miscellaneous Investment Vehicles | General meeting / Board Meeting |
15 Feb 2023 16:01 CET |
NEPI ROCKCASTLE N.V. | Reminder For Results Presentation Live Webcast | 35101010 Real Estate Holding and Development | Other subject |
15 Feb 2023 11:45 CET |
Coca-Cola Europacific Partners plc | Directorate Change | 45101020 Soft Drinks | Legal |
15 Feb 2023 07:45 CET |
KONINKLIJKE AHOLD DELHAIZE N.V. | Ahold Delhaize delivers increased cost savings, supporting strong Q4 financial results; 2023 outlook reinforces commitment to Leading Together ambitions | 45201010 Food Retailers and Wholesalers | Other subject |
15 Feb 2023 07:30 CET |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
15 Feb 2023 07:30 CET |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
15 Feb 2023 07:01 CET |
HEINEKEN HOLDING | Heineken Holding N.V. reports 2022 full year results | 45101010 Brewers | Other subject |
15 Feb 2023 07:00 CET |
VOPAK | Vopak reports on FY 2022 and Q4 2022 financial results | 50206060 Transportation Services | Other subject |
15 Feb 2023 07:00 CET |
HEINEKEN | Heineken N.V. reports 2022 full year results | 45101010 Brewers | Commercial results |
14 Feb 2023 18:08 CET |
SHELL PLC | Transaction in Own Shares | 60101000 Integrated Oil and Gas | Other subject |
14 Feb 2023 16:05 CET |
PROSUS | Update on Repurchase Programme | 10101020 Consumer Digital Services | Other subject |
14 Feb 2023 08:00 CET |
KONINKLIJKE AHOLD DELHAIZE N.V. | Ahold Delhaize share buyback update | 45201010 Food Retailers and Wholesalers | Other subject |
14 Feb 2023 07:30 CET |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
14 Feb 2023 07:30 CET |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
14 Feb 2023 05:30 CET |
OCI N.V. | OCI N.V. Reports Full Year 2022 Adjusted Net Profit of $1.3 Billion | 55201015 Fertilizers | Other subject |
13 Feb 2023 18:24 CET |
SHELL PLC | Transaction in Own Shares | 60101000 Integrated Oil and Gas | Other subject |
13 Feb 2023 18:20 CET |
BOUSSARD GAVAUDAN HOLD LTD GBP | Boussard & Gavaudan Holding Ltd (GBP): Newsletter January 2023 | 30204000 Closed End Investments | Other subject |
13 Feb 2023 18:20 CET |
Boussard Gavaudan | Boussard & Gavaudan Holding Ltd (EUR): Newsletter January 2023 | 30204000 Closed End Investments | Other subject |
13 Feb 2023 17:56 CET |
FL ENTERTAINMENT | FL Entertainment: weekly share transactions | 40301010 Entertainment | Other financial transaction |
13 Feb 2023 10:55 CET |
Volta Finance Limited | Volta Finance Limited - Net Asset Value as at 31 January 2023 | 30204000 Closed End Investments | Other subject |
13 Feb 2023 08:10 CET |
EXOR | Exor N.V.: Periodic Report on the Buyback Program | 30202000 Diversified Financial Services | Other subject |
13 Feb 2023 08:00 CET |
KPN KON | Press release: KPN nominates Herman Dijkhuizen to Supervisory Board | 15102015 Telecommunications Services | Other subject |
13 Feb 2023 07:30 CET |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
13 Feb 2023 07:30 CET |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
10 Feb 2023 18:07 CET |
ALUMEXX N.V. | Alumexx roept BAVA bijeen voor succesvolle afronding overnames Euroscaffold en ASC Group | 55201000 Chemicals: Diversified | General meeting / Board Meeting |
10 Feb 2023 17:54 CET |
SHELL PLC | Transaction in Own Shares | 60101000 Integrated Oil and Gas | Other subject |
10 Feb 2023 07:30 CET |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
10 Feb 2023 07:30 CET |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
10 Feb 2023 07:07 CET |
APERAM | Aperam announces dividend payment schedule for 2023 | 55102010 Iron and Steel | Dividend |
10 Feb 2023 07:07 CET |
APERAM | Aperam annonce son calendrier de versement de dividendes pour 2023 | 55102010 Iron and Steel | Dividend |
10 Feb 2023 07:03 CET |
APERAM | Aperam & Econick have formed a JV called Botanickel to become a world leader in the responsible and sustainable production of biosourced nickel for the stainless steel industry. | 55102010 Iron and Steel | Joint venture |
10 Feb 2023 07:03 CET |
APERAM | Aperam & Econick ont créé une joint-venture Botanickel avec l’ambition de devenir un leader mondial dans la production responsable et durable de nickel biosourcé pour l’industrie de l’acier inoxydable | 55102010 Iron and Steel | Joint venture |
10 Feb 2023 06:58 CET |
APERAM | Full year and fourth quarter 2022 results | 55102010 Iron and Steel | Commercial results |
10 Feb 2023 06:58 CET |
APERAM | Résultats de l’année 2022 et du quatrième trimestre 2022 | 55102010 Iron and Steel | Commercial results |
09 Feb 2023 22:01 CET |
GALAPAGOS | Galapagos heeft bemoedigende eerste gegevens gepresenteerd over veiligheid en werkzaamheid van point-of-care vervaardigde CAR-T kandidaat, GLPG5201, in rrCLL, op EBMT-EHA 2023 | 20103010 Biotechnology | Other subject |
09 Feb 2023 22:01 CET |
GALAPAGOS | Galapagos presented encouraging initial safety and efficacy data at 2023 EBMT-EHA for point-of-care manufactured CAR-T candidate, GLPG5201, in rrCLL | 20103010 Biotechnology | Other subject |
09 Feb 2023 18:05 CET |
SHELL PLC | Transaction in Own Shares | 60101000 Integrated Oil and Gas | Other subject |
09 Feb 2023 10:00 CET |
WOLTERS KLUWER | Share Buyback Transaction Details February 2 – February 8, 2023 | 40301030 Publishing | Share introduction and issues |
09 Feb 2023 07:30 CET |
UNIBAIL-RODAMCO-WESTFIELD | Unibail-Rodamco-Westfield Reports FY-2022 Earnings | 35102045 Retail REITs | Other subject |
09 Feb 2023 07:30 CET |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
09 Feb 2023 07:30 CET |
FLOW TRADERS | FLOW TRADERS Q422 RESULTS | 30202015 Investment Services | Commercial results |
09 Feb 2023 07:30 CET |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
09 Feb 2023 07:00 CET |
WERELDHAVE Gewone aandelen | Wereldhave Full-year results 2022 | 35102045 Retail REITs | Commercial results |
09 Feb 2023 07:00 CET |
AEGON | Aegon reports fourth quarter 2022 results | 30301010 Life Insurance | Commercial results |
09 Feb 2023 07:00 CET |
ARCELORMITTAL SA | ArcelorMittal reports fourth quarter 2022 results | 55102010 Iron and Steel | Other subject |
09 Feb 2023 07:00 CET |
AEGON | Aegon rapporteert resultaten over vierde kwartaal 2022 | 30301010 Life Insurance | Commercial results |
08 Feb 2023 22:45 CET |
PERSHING SQUARE HOLDING | Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value and Year-To-Date Return As Of 7 February 2023 | 30204000 Closed End Investments | Other subject |
08 Feb 2023 22:01 CET |
GALAPAGOS | Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease | 20103010 Biotechnology | Other subject |
08 Feb 2023 22:01 CET |
GALAPAGOS | Galapagos kondigt topline resultaten aan van fase 3 DIVERSITY-studie met filgotinib bij de ziekte van Crohn | 20103010 Biotechnology | Other subject |